

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 9.79625748 |
| 2 | actin-mediated cell contraction (GO:0070252) | 8.59617158 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 8.47699030 |
| 4 | skeletal muscle contraction (GO:0003009) | 8.10358413 |
| 5 | regulation of relaxation of muscle (GO:1901077) | 6.84792675 |
| 6 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.47369671 |
| 7 | myofibril assembly (GO:0030239) | 6.45240706 |
| 8 | response to muscle activity (GO:0014850) | 6.37927520 |
| 9 | striated muscle contraction (GO:0006941) | 6.32930886 |
| 10 | locomotory exploration behavior (GO:0035641) | 6.29528843 |
| 11 | synaptic vesicle maturation (GO:0016188) | 6.28981380 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.22050933 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.14334405 |
| 14 | actin filament-based movement (GO:0030048) | 6.12100913 |
| 15 | sarcomere organization (GO:0045214) | 6.01643830 |
| 16 | response to inactivity (GO:0014854) | 5.99712159 |
| 17 | skeletal muscle fiber development (GO:0048741) | 5.94091756 |
| 18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.63132134 |
| 19 | vocalization behavior (GO:0071625) | 5.60536529 |
| 20 | creatine metabolic process (GO:0006600) | 5.58942900 |
| 21 | myotube cell development (GO:0014904) | 5.47637518 |
| 22 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.44898638 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.41286221 |
| 24 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.40346414 |
| 25 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.37954273 |
| 26 | synaptic vesicle exocytosis (GO:0016079) | 5.28234412 |
| 27 | glutamate secretion (GO:0014047) | 5.12705978 |
| 28 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.04817201 |
| 29 | cardiac myofibril assembly (GO:0055003) | 5.04720589 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 4.98155230 |
| 31 | plasma membrane repair (GO:0001778) | 4.92907079 |
| 32 | neuronal action potential propagation (GO:0019227) | 4.91408490 |
| 33 | muscle contraction (GO:0006936) | 4.82514631 |
| 34 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.81723635 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.80671440 |
| 36 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.75290611 |
| 37 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.69701990 |
| 38 | cardiac muscle contraction (GO:0060048) | 4.68665804 |
| 39 | muscle fiber development (GO:0048747) | 4.68160604 |
| 40 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.66806865 |
| 41 | glycogen catabolic process (GO:0005980) | 4.62044498 |
| 42 | protein localization to synapse (GO:0035418) | 4.60320535 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.59206971 |
| 44 | regulation of cell communication by electrical coupling (GO:0010649) | 4.57721068 |
| 45 | exploration behavior (GO:0035640) | 4.57645747 |
| 46 | skeletal muscle adaptation (GO:0043501) | 4.56571362 |
| 47 | regulation of actin filament-based movement (GO:1903115) | 4.53523053 |
| 48 | dendritic spine morphogenesis (GO:0060997) | 4.48091393 |
| 49 | regulation of sequestering of triglyceride (GO:0010889) | 4.44357218 |
| 50 | neurotransmitter secretion (GO:0007269) | 4.38728841 |
| 51 | regulation of synaptic vesicle transport (GO:1902803) | 4.38004246 |
| 52 | actomyosin structure organization (GO:0031032) | 4.37993822 |
| 53 | muscle system process (GO:0003012) | 4.33961916 |
| 54 | glucan catabolic process (GO:0009251) | 4.32063262 |
| 55 | otic vesicle formation (GO:0030916) | 4.31024215 |
| 56 | synaptic transmission, glutamatergic (GO:0035249) | 4.30866947 |
| 57 | skeletal muscle tissue development (GO:0007519) | 4.28831803 |
| 58 | glycogen biosynthetic process (GO:0005978) | 4.25593134 |
| 59 | glucan biosynthetic process (GO:0009250) | 4.25593134 |
| 60 | long-term memory (GO:0007616) | 4.23698289 |
| 61 | cardiac muscle hypertrophy (GO:0003300) | 4.20313607 |
| 62 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.19062481 |
| 63 | glutamate receptor signaling pathway (GO:0007215) | 4.13706368 |
| 64 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.11894793 |
| 65 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.08803345 |
| 66 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.06529522 |
| 67 | positive regulation of membrane potential (GO:0045838) | 4.05382335 |
| 68 | striated muscle hypertrophy (GO:0014897) | 4.04001775 |
| 69 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.01923993 |
| 70 | layer formation in cerebral cortex (GO:0021819) | 4.01678704 |
| 71 | neuron-neuron synaptic transmission (GO:0007270) | 4.01350490 |
| 72 | cellular polysaccharide catabolic process (GO:0044247) | 3.95071253 |
| 73 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.93535030 |
| 74 | cellular potassium ion homeostasis (GO:0030007) | 3.90360565 |
| 75 | neuromuscular process controlling balance (GO:0050885) | 3.86256014 |
| 76 | striated muscle adaptation (GO:0014888) | 3.85796015 |
| 77 | positive regulation of synapse maturation (GO:0090129) | 3.84426940 |
| 78 | sodium ion export (GO:0071436) | 3.81569875 |
| 79 | adult heart development (GO:0007512) | 3.80925094 |
| 80 | regulation of postsynaptic membrane potential (GO:0060078) | 3.80630240 |
| 81 | regulation of synaptic plasticity (GO:0048167) | 3.78947184 |
| 82 | gamma-aminobutyric acid transport (GO:0015812) | 3.77684588 |
| 83 | regulation of membrane repolarization (GO:0060306) | 3.76015845 |
| 84 | skeletal muscle tissue regeneration (GO:0043403) | 3.73568521 |
| 85 | activation of protein kinase A activity (GO:0034199) | 3.66566692 |
| 86 | proline transport (GO:0015824) | 3.65056420 |
| 87 | neuron cell-cell adhesion (GO:0007158) | 3.62393325 |
| 88 | ubiquinone biosynthetic process (GO:0006744) | 3.61794512 |
| 89 | somite development (GO:0061053) | 3.61092389 |
| 90 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.58689356 |
| 91 | prepulse inhibition (GO:0060134) | 3.58104982 |
| 92 | behavioral response to nicotine (GO:0035095) | 3.57682402 |
| 93 | auditory behavior (GO:0031223) | 3.57360206 |
| 94 | polysaccharide catabolic process (GO:0000272) | 3.54023409 |
| 95 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.52798130 |
| 96 | muscle cell fate commitment (GO:0042693) | 3.52428453 |
| 97 | muscle hypertrophy (GO:0014896) | 3.51013071 |
| 98 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.50940475 |
| 99 | striated muscle cell development (GO:0055002) | 3.49422791 |
| 100 | dendritic spine organization (GO:0097061) | 3.47345109 |
| 101 | membrane depolarization during action potential (GO:0086010) | 3.45404524 |
| 102 | neurotransmitter transport (GO:0006836) | 3.43597144 |
| 103 | regulation of neurotransmitter secretion (GO:0046928) | 3.42771884 |
| 104 | neuromuscular synaptic transmission (GO:0007274) | 3.41911137 |
| 105 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.41042415 |
| 106 | regulation of striated muscle contraction (GO:0006942) | 3.40963772 |
| 107 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.39785922 |
| 108 | positive regulation of neurotransmitter transport (GO:0051590) | 3.38832085 |
| 109 | NADH metabolic process (GO:0006734) | 3.38232213 |
| 110 | muscle structure development (GO:0061061) | 3.37933065 |
| 111 | transmission of nerve impulse (GO:0019226) | 3.37598079 |
| 112 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.37430414 |
| 113 | cell communication by electrical coupling (GO:0010644) | 3.37251762 |
| 114 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.35809943 |
| 115 | positive regulation of fatty acid oxidation (GO:0046321) | 3.34246215 |
| 116 | muscle organ development (GO:0007517) | 3.34188927 |
| 117 | membrane depolarization (GO:0051899) | 3.34108889 |
| 118 | muscle tissue morphogenesis (GO:0060415) | 3.33698323 |
| 119 | synaptic vesicle endocytosis (GO:0048488) | 3.33321175 |
| 120 | glycogen metabolic process (GO:0005977) | 3.33290357 |
| 121 | long-term synaptic potentiation (GO:0060291) | 3.33122262 |
| 122 | regulation of ARF protein signal transduction (GO:0032012) | 3.30898668 |
| 123 | regulation of dendritic spine development (GO:0060998) | 3.30447097 |
| 124 | ubiquinone metabolic process (GO:0006743) | 3.28539383 |
| 125 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.28253662 |
| 126 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.27829893 |
| 127 | glucan metabolic process (GO:0044042) | 3.25942201 |
| 128 | cellular glucan metabolic process (GO:0006073) | 3.25942201 |
| 129 | regulation of neurotransmitter levels (GO:0001505) | 3.25781229 |
| 130 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.25498828 |
| 131 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.25139282 |
| 132 | muscle cell cellular homeostasis (GO:0046716) | 3.24476854 |
| 133 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.23957573 |
| 134 | neuromuscular process controlling posture (GO:0050884) | 3.23631876 |
| 135 | regulation of neurotransmitter transport (GO:0051588) | 3.22741950 |
| 136 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.22438805 |
| 137 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.22438805 |
| 138 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.22236099 |
| 139 | response to activity (GO:0014823) | 3.21911623 |
| 140 | striated muscle atrophy (GO:0014891) | 3.19787382 |
| 141 | chemosensory behavior (GO:0007635) | 3.19728694 |
| 142 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.19639069 |
| 143 | neuronal ion channel clustering (GO:0045161) | 3.19106101 |
| 144 | response to auditory stimulus (GO:0010996) | 3.17503271 |
| 145 | positive regulation of dendritic spine development (GO:0060999) | 3.16908452 |
| 146 | positive regulation of cation channel activity (GO:2001259) | 3.15022462 |
| 147 | 2-oxoglutarate metabolic process (GO:0006103) | 3.14798197 |
| 148 | L-amino acid import (GO:0043092) | 3.14763059 |
| 149 | glycine transport (GO:0015816) | 3.13718754 |
| 150 | muscle atrophy (GO:0014889) | 3.13718606 |
| 151 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.11379067 |
| 152 | myotube differentiation (GO:0014902) | 3.09820708 |
| 153 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.08642070 |
| 154 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.08642070 |
| 155 | membrane hyperpolarization (GO:0060081) | 3.07791602 |
| 156 | regulation of vesicle fusion (GO:0031338) | 3.07662874 |
| 157 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.07380252 |
| 158 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.07265283 |
| 159 | neuromuscular process (GO:0050905) | 3.06698878 |
| 160 | dendrite morphogenesis (GO:0048813) | 3.06327267 |
| 161 | learning (GO:0007612) | 3.06021605 |
| 162 | muscle adaptation (GO:0043500) | 3.05047649 |
| 163 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.04526844 |
| 164 | behavioral response to cocaine (GO:0048148) | 3.03332556 |
| 165 | long term synaptic depression (GO:0060292) | 3.02571945 |
| 166 | negative regulation of muscle contraction (GO:0045932) | 3.01802978 |
| 167 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.00689594 |
| 168 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.00279672 |
| 169 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.99895472 |
| 170 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.99849789 |
| 171 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.99628703 |
| 172 | behavioral defense response (GO:0002209) | 2.99015438 |
| 173 | behavioral fear response (GO:0001662) | 2.99015438 |
| 174 | striated muscle tissue development (GO:0014706) | 2.98814868 |
| 175 | regulation of synaptic transmission (GO:0050804) | 2.97832133 |
| 176 | positive regulation of synaptic transmission (GO:0050806) | 2.97399286 |
| 177 | cardiac muscle cell development (GO:0055013) | 2.96688186 |
| 178 | muscle cell development (GO:0055001) | 2.96238240 |
| 179 | muscle organ morphogenesis (GO:0048644) | 2.96059262 |
| 180 | vesicle transport along microtubule (GO:0047496) | 2.95497445 |
| 181 | quinone biosynthetic process (GO:1901663) | 2.94084200 |
| 182 | response to histamine (GO:0034776) | 2.93375274 |
| 183 | innervation (GO:0060384) | 2.93011343 |
| 184 | neuron recognition (GO:0008038) | 2.92986611 |
| 185 | heart process (GO:0003015) | 2.92870436 |
| 186 | heart contraction (GO:0060047) | 2.92870436 |
| 187 | synaptic transmission (GO:0007268) | 2.92424609 |
| 188 | response to caffeine (GO:0031000) | 2.91230141 |
| 189 | potassium ion import (GO:0010107) | 2.91219709 |
| 190 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.90199200 |
| 191 | regulation of synapse maturation (GO:0090128) | 2.89586352 |
| 192 | fructose metabolic process (GO:0006000) | 2.88751029 |
| 193 | positive regulation of myoblast differentiation (GO:0045663) | 2.88361608 |
| 194 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.87681442 |
| 195 | IMP metabolic process (GO:0046040) | 2.87154348 |
| 196 | actin-myosin filament sliding (GO:0033275) | 10.5111795 |
| 197 | muscle filament sliding (GO:0030049) | 10.5111795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.10122932 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.90685866 |
| 3 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.16828100 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.14309402 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07319682 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05567789 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.00711163 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.96933632 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.93910777 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.87763551 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.81115723 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.81115723 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.76352089 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.67452069 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.58075065 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.57302927 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.53740253 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.52716405 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.51783917 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41064651 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.38421942 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36911174 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.36802142 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.34655483 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.29651510 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.28922890 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.23507769 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.21447116 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05428548 |
| 30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.97252788 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88444462 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.82300481 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.76422406 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75215222 |
| 35 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.70915329 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70689126 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.67348615 |
| 38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58917868 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54385916 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.53053236 |
| 41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.52061458 |
| 42 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.51229980 |
| 43 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.45777755 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.45625827 |
| 45 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.44956299 |
| 46 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.44942101 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.44595619 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.44145785 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41111109 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39836127 |
| 51 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.38932653 |
| 52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36617787 |
| 53 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.36002541 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.34784597 |
| 55 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34509948 |
| 56 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32660621 |
| 57 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32581028 |
| 58 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.32025679 |
| 59 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30504825 |
| 60 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.27471788 |
| 61 | AR_19668381_ChIP-Seq_PC3_Human | 1.26542016 |
| 62 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26508776 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.26309825 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26165087 |
| 65 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26128661 |
| 66 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.25298685 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.24599307 |
| 68 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.23351261 |
| 69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23308935 |
| 70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20620959 |
| 71 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.19371291 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.19134214 |
| 73 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.19134214 |
| 74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.18245321 |
| 75 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17404832 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16909817 |
| 77 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.16215332 |
| 78 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16039803 |
| 79 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15947890 |
| 80 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.15126456 |
| 81 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.15118965 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14486252 |
| 83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13784748 |
| 84 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.12741430 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12400651 |
| 86 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11490160 |
| 87 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10776924 |
| 88 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.10772305 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08309549 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07305493 |
| 91 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07267540 |
| 92 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06211412 |
| 93 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06211412 |
| 94 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06051357 |
| 95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05557380 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04658704 |
| 97 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04052233 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03930850 |
| 99 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03909758 |
| 100 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03862967 |
| 101 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03862967 |
| 102 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02795677 |
| 103 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02766642 |
| 104 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02415294 |
| 105 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01516611 |
| 106 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01194998 |
| 107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01146353 |
| 108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00205554 |
| 109 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00118034 |
| 110 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.99969307 |
| 111 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97536895 |
| 112 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97304927 |
| 113 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97224934 |
| 114 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.97193099 |
| 115 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.96996896 |
| 116 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.96268031 |
| 117 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96102842 |
| 118 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95682827 |
| 119 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.95593401 |
| 120 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94971388 |
| 121 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94971388 |
| 122 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94295820 |
| 123 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93908667 |
| 124 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93893025 |
| 125 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93556447 |
| 126 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93464332 |
| 127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92784407 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92018271 |
| 129 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91956994 |
| 130 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91666097 |
| 131 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91474676 |
| 132 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.90882758 |
| 133 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.90343735 |
| 134 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89417085 |
| 135 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88706134 |
| 136 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87747134 |
| 137 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.87218696 |
| 138 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86451030 |
| 139 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86286635 |
| 140 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.86258791 |
| 141 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84971293 |
| 142 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84573495 |
| 143 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84015771 |
| 144 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.83167311 |
| 145 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.81694120 |
| 146 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.81283997 |
| 147 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81000331 |
| 148 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80383865 |
| 149 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.78904082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.53091067 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 4.31236359 |
| 3 | MP0003880_abnormal_central_pattern | 4.26646724 |
| 4 | MP0002822_catalepsy | 4.17664974 |
| 5 | MP0004270_analgesia | 3.98755868 |
| 6 | MP0009745_abnormal_behavioral_response | 3.52057042 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.43650391 |
| 8 | MP0002064_seizures | 3.18039543 |
| 9 | MP0009046_muscle_twitch | 3.12214060 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.74598834 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.62578048 |
| 12 | MP0002272_abnormal_nervous_system | 2.60676404 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.53636976 |
| 14 | MP0001486_abnormal_startle_reflex | 2.52636358 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.52085329 |
| 16 | MP0002332_abnormal_exercise_endurance | 2.47233872 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.39528980 |
| 18 | MP0004084_abnormal_cardiac_muscle | 2.39253465 |
| 19 | MP0008569_lethality_at_weaning | 2.24102021 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.14726524 |
| 21 | MP0005330_cardiomyopathy | 2.09834421 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.98878820 |
| 23 | MP0001440_abnormal_grooming_behavior | 1.97434350 |
| 24 | MP0004858_abnormal_nervous_system | 1.85943619 |
| 25 | MP0002736_abnormal_nociception_after | 1.84023849 |
| 26 | MP0002972_abnormal_cardiac_muscle | 1.83419342 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.82901403 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.80969671 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 1.80345159 |
| 30 | MP0004811_abnormal_neuron_physiology | 1.79903464 |
| 31 | MP0000751_myopathy | 1.78616816 |
| 32 | MP0001970_abnormal_pain_threshold | 1.77293937 |
| 33 | MP0002067_abnormal_sensory_capabilities | 1.76901496 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.72902302 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.72509203 |
| 36 | MP0003329_amyloid_beta_deposits | 1.70169534 |
| 37 | MP0004924_abnormal_behavior | 1.67866523 |
| 38 | MP0005386_behavior/neurological_phenoty | 1.67866523 |
| 39 | MP0005670_abnormal_white_adipose | 1.67212116 |
| 40 | MP0003879_abnormal_hair_cell | 1.64583365 |
| 41 | MP0005451_abnormal_body_composition | 1.62177277 |
| 42 | MP0000733_abnormal_muscle_development | 1.59921316 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.58977687 |
| 44 | MP0002184_abnormal_innervation | 1.58261314 |
| 45 | MP0002108_abnormal_muscle_morphology | 1.54100054 |
| 46 | MP0003633_abnormal_nervous_system | 1.48632354 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.48018383 |
| 48 | MP0000955_abnormal_spinal_cord | 1.45962358 |
| 49 | MP0004885_abnormal_endolymph | 1.43341924 |
| 50 | MP0002127_abnormal_cardiovascular_syste | 1.41812482 |
| 51 | MP0000778_abnormal_nervous_system | 1.41410175 |
| 52 | MP0002066_abnormal_motor_capabilities/c | 1.40212329 |
| 53 | MP0000372_irregular_coat_pigmentation | 1.37990441 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.30420465 |
| 55 | MP0003646_muscle_fatigue | 1.29727058 |
| 56 | MP0006292_abnormal_olfactory_placode | 1.28594918 |
| 57 | MP0005266_abnormal_metabolism | 1.26170619 |
| 58 | MP0003075_altered_response_to | 1.25599051 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.25515312 |
| 60 | MP0003631_nervous_system_phenotype | 1.23270003 |
| 61 | MP0001544_abnormal_cardiovascular_syste | 1.22914982 |
| 62 | MP0005385_cardiovascular_system_phenoty | 1.22914982 |
| 63 | MP0001984_abnormal_olfaction | 1.17464509 |
| 64 | MP0010630_abnormal_cardiac_muscle | 1.17343515 |
| 65 | MP0008872_abnormal_physiological_respon | 1.13416573 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 1.12295358 |
| 67 | MP0008775_abnormal_heart_ventricle | 1.11476735 |
| 68 | MP0001661_extended_life_span | 1.09813255 |
| 69 | MP0001529_abnormal_vocalization | 1.09534515 |
| 70 | MP0004215_abnormal_myocardial_fiber | 1.09078306 |
| 71 | MP0008874_decreased_physiological_sensi | 1.06966426 |
| 72 | MP0008961_abnormal_basal_metabolism | 1.06959032 |
| 73 | MP0001905_abnormal_dopamine_level | 1.04920983 |
| 74 | MP0003787_abnormal_imprinting | 1.04228261 |
| 75 | MP0004134_abnormal_chest_morphology | 1.04150421 |
| 76 | MP0001502_abnormal_circadian_rhythm | 1.04124698 |
| 77 | MP0004142_abnormal_muscle_tone | 1.02267927 |
| 78 | MP0002152_abnormal_brain_morphology | 1.01684977 |
| 79 | MP0003283_abnormal_digestive_organ | 1.00335629 |
| 80 | MP0004085_abnormal_heartbeat | 1.00192588 |
| 81 | MP0001177_atelectasis | 0.97938889 |
| 82 | MP0004233_abnormal_muscle_weight | 0.97856145 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.95891490 |
| 84 | MP0002971_abnormal_brown_adipose | 0.95883212 |
| 85 | MP0003137_abnormal_impulse_conducting | 0.94240246 |
| 86 | MP0000747_muscle_weakness | 0.93635306 |
| 87 | MP0004510_myositis | 0.92806788 |
| 88 | MP0000749_muscle_degeneration | 0.92787959 |
| 89 | MP0004484_altered_response_of | 0.90769802 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.90263819 |
| 91 | MP0002069_abnormal_eating/drinking_beha | 0.90230803 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.89897428 |
| 93 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87849955 |
| 94 | MP0003690_abnormal_glial_cell | 0.86618830 |
| 95 | MP0003136_yellow_coat_color | 0.86510290 |
| 96 | MP0003632_abnormal_nervous_system | 0.85627352 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.85550185 |
| 98 | MP0000920_abnormal_myelination | 0.84567935 |
| 99 | MP0002229_neurodegeneration | 0.84208756 |
| 100 | MP0004130_abnormal_muscle_cell | 0.83787701 |
| 101 | MP0000049_abnormal_middle_ear | 0.83497556 |
| 102 | MP0005535_abnormal_body_temperature | 0.83139039 |
| 103 | MP0004036_abnormal_muscle_relaxation | 0.83110532 |
| 104 | MP0005645_abnormal_hypothalamus_physiol | 0.81810107 |
| 105 | MP0005620_abnormal_muscle_contractility | 0.78207646 |
| 106 | MP0006276_abnormal_autonomic_nervous | 0.76042360 |
| 107 | MP0005409_darkened_coat_color | 0.76024979 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.75557726 |
| 109 | MP0006138_congestive_heart_failure | 0.74126946 |
| 110 | MP0004147_increased_porphyrin_level | 0.73544597 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.70828563 |
| 112 | MP0002090_abnormal_vision | 0.70125586 |
| 113 | MP0003634_abnormal_glial_cell | 0.69801626 |
| 114 | MP0000604_amyloidosis | 0.68614823 |
| 115 | MP0004043_abnormal_pH_regulation | 0.67193105 |
| 116 | MP0004087_abnormal_muscle_fiber | 0.66946556 |
| 117 | MP0009250_abnormal_appendicular_skeleto | 0.66748169 |
| 118 | MP0010234_abnormal_vibrissa_follicle | 0.66504846 |
| 119 | MP0002160_abnormal_reproductive_system | 0.65863292 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.64329513 |
| 121 | MP0005499_abnormal_olfactory_system | 0.64217588 |
| 122 | MP0005394_taste/olfaction_phenotype | 0.64217588 |
| 123 | MP0002106_abnormal_muscle_physiology | 0.63254406 |
| 124 | MP0005551_abnormal_eye_electrophysiolog | 0.62740417 |
| 125 | MP0000759_abnormal_skeletal_muscle | 0.62689021 |
| 126 | MP0002269_muscular_atrophy | 0.61764761 |
| 127 | MP0001485_abnormal_pinna_reflex | 0.60723587 |
| 128 | MP0005623_abnormal_meninges_morphology | 0.60582541 |
| 129 | MP0002249_abnormal_larynx_morphology | 0.59897886 |
| 130 | MP0001963_abnormal_hearing_physiology | 0.59371644 |
| 131 | MP0004742_abnormal_vestibular_system | 0.59224053 |
| 132 | MP0001188_hyperpigmentation | 0.58710032 |
| 133 | MP0009379_abnormal_foot_pigmentation | 0.57677235 |
| 134 | MP0005369_muscle_phenotype | 0.56021889 |
| 135 | MP0008789_abnormal_olfactory_epithelium | 0.55973689 |
| 136 | MP0002752_abnormal_somatic_nervous | 0.54846588 |
| 137 | MP0005375_adipose_tissue_phenotype | 0.54442852 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.52416243 |
| 139 | MP0005187_abnormal_penis_morphology | 0.50785533 |
| 140 | MP0000003_abnormal_adipose_tissue | 0.49988273 |
| 141 | MP0000026_abnormal_inner_ear | 0.48434483 |
| 142 | MP0003938_abnormal_ear_development | 0.47833131 |
| 143 | MP0002138_abnormal_hepatobiliary_system | 0.46492455 |
| 144 | MP0003950_abnormal_plasma_membrane | 0.46345722 |
| 145 | MP0002078_abnormal_glucose_homeostasis | 0.44460887 |
| 146 | MP0001299_abnormal_eye_distance/ | 0.42744832 |
| 147 | MP0002277_abnormal_respiratory_mucosa | 0.42679123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.94763511 |
| 2 | Type 1 muscle fiber predominance (HP:0003803) | 7.80542003 |
| 3 | Focal motor seizures (HP:0011153) | 7.64484598 |
| 4 | Focal seizures (HP:0007359) | 5.68684283 |
| 5 | Distal arthrogryposis (HP:0005684) | 5.36641400 |
| 6 | Myopathic facies (HP:0002058) | 5.31453084 |
| 7 | Visual hallucinations (HP:0002367) | 5.16754123 |
| 8 | EMG: myopathic abnormalities (HP:0003458) | 4.84785130 |
| 9 | Action tremor (HP:0002345) | 4.68859973 |
| 10 | Rimmed vacuoles (HP:0003805) | 4.55234995 |
| 11 | Muscle fiber splitting (HP:0003555) | 4.51164104 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 4.44674688 |
| 13 | Epileptic encephalopathy (HP:0200134) | 4.33862172 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 4.32262074 |
| 15 | Rhabdomyolysis (HP:0003201) | 4.23089372 |
| 16 | Myoglobinuria (HP:0002913) | 4.22842193 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 4.15138320 |
| 18 | Atonic seizures (HP:0010819) | 4.10943779 |
| 19 | Febrile seizures (HP:0002373) | 4.07072736 |
| 20 | Round ear (HP:0100830) | 4.06873678 |
| 21 | Neck muscle weakness (HP:0000467) | 4.05599729 |
| 22 | Absent phalangeal crease (HP:0006109) | 3.97883770 |
| 23 | Ulnar deviation of the wrist (HP:0003049) | 3.82625361 |
| 24 | Poor eye contact (HP:0000817) | 3.78093223 |
| 25 | Absence seizures (HP:0002121) | 3.75765486 |
| 26 | Broad-based gait (HP:0002136) | 3.74454959 |
| 27 | Gaze-evoked nystagmus (HP:0000640) | 3.73445561 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 3.71052620 |
| 29 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.66633428 |
| 30 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.59251159 |
| 31 | Dysdiadochokinesis (HP:0002075) | 3.56381914 |
| 32 | Ankle clonus (HP:0011448) | 3.54969971 |
| 33 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.53365792 |
| 34 | Subaortic stenosis (HP:0001682) | 3.53365792 |
| 35 | Calcaneovalgus deformity (HP:0001848) | 3.51973160 |
| 36 | Dialeptic seizures (HP:0011146) | 3.47544065 |
| 37 | Depression (HP:0000716) | 3.40180729 |
| 38 | Impaired social interactions (HP:0000735) | 3.40000119 |
| 39 | Abnormal social behavior (HP:0012433) | 3.40000119 |
| 40 | Dysmetria (HP:0001310) | 3.35657904 |
| 41 | Frequent falls (HP:0002359) | 3.32333209 |
| 42 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.30980848 |
| 43 | Abnormal finger flexion creases (HP:0006143) | 3.26502509 |
| 44 | Abnormality of the lower motor neuron (HP:0002366) | 3.22553758 |
| 45 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.22181541 |
| 46 | Dysmetric saccades (HP:0000641) | 3.18930977 |
| 47 | Muscle stiffness (HP:0003552) | 3.14627556 |
| 48 | Deformed tarsal bones (HP:0008119) | 3.14022114 |
| 49 | Anxiety (HP:0000739) | 3.13398227 |
| 50 | Annular pancreas (HP:0001734) | 3.09746512 |
| 51 | Postural instability (HP:0002172) | 3.08322480 |
| 52 | Areflexia of lower limbs (HP:0002522) | 3.06235953 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 3.01985549 |
| 54 | Impaired smooth pursuit (HP:0007772) | 3.01724897 |
| 55 | Ventricular fibrillation (HP:0001663) | 2.98025350 |
| 56 | Bundle branch block (HP:0011710) | 2.97656364 |
| 57 | Exercise-induced myalgia (HP:0003738) | 2.96940569 |
| 58 | Intention tremor (HP:0002080) | 2.90296122 |
| 59 | Truncal ataxia (HP:0002078) | 2.83126685 |
| 60 | Urinary urgency (HP:0000012) | 2.82919681 |
| 61 | Increased connective tissue (HP:0009025) | 2.82166565 |
| 62 | Scanning speech (HP:0002168) | 2.81278637 |
| 63 | Amblyopia (HP:0000646) | 2.77062125 |
| 64 | Generalized muscle weakness (HP:0003324) | 2.75447208 |
| 65 | EMG: neuropathic changes (HP:0003445) | 2.74950020 |
| 66 | Genetic anticipation (HP:0003743) | 2.73979084 |
| 67 | Torticollis (HP:0000473) | 2.73953931 |
| 68 | Papilledema (HP:0001085) | 2.73076752 |
| 69 | Distal lower limb muscle weakness (HP:0009053) | 2.71265373 |
| 70 | Hemiplegia (HP:0002301) | 2.65362237 |
| 71 | Asymmetric septal hypertrophy (HP:0001670) | 2.64177714 |
| 72 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.62097327 |
| 73 | Hyperventilation (HP:0002883) | 2.61506873 |
| 74 | Focal dystonia (HP:0004373) | 2.61166724 |
| 75 | Increased variability in muscle fiber diameter (HP:0003557) | 2.59609570 |
| 76 | Stereotypic behavior (HP:0000733) | 2.58650589 |
| 77 | Impaired vibratory sensation (HP:0002495) | 2.55618713 |
| 78 | Malignant hyperthermia (HP:0002047) | 2.54886014 |
| 79 | Spastic gait (HP:0002064) | 2.53230735 |
| 80 | Fetal akinesia sequence (HP:0001989) | 2.49132375 |
| 81 | Abnormal eating behavior (HP:0100738) | 2.46993938 |
| 82 | Slender build (HP:0001533) | 2.45907150 |
| 83 | Bradykinesia (HP:0002067) | 2.42840527 |
| 84 | Lower limb amyotrophy (HP:0007210) | 2.42655038 |
| 85 | Mutism (HP:0002300) | 2.40597772 |
| 86 | Hemiparesis (HP:0001269) | 2.40072896 |
| 87 | Pointed chin (HP:0000307) | 2.39598350 |
| 88 | Resting tremor (HP:0002322) | 2.38619924 |
| 89 | Oligomenorrhea (HP:0000876) | 2.36016188 |
| 90 | Bulbar palsy (HP:0001283) | 2.31410110 |
| 91 | Sudden death (HP:0001699) | 2.27627107 |
| 92 | Abnormal EKG (HP:0003115) | 2.25857824 |
| 93 | Craniofacial dystonia (HP:0012179) | 2.23678378 |
| 94 | Weak cry (HP:0001612) | 2.22907889 |
| 95 | Megalencephaly (HP:0001355) | 2.22319379 |
| 96 | Abnormality of binocular vision (HP:0011514) | 2.21664292 |
| 97 | Diplopia (HP:0000651) | 2.21664292 |
| 98 | Status epilepticus (HP:0002133) | 2.21569656 |
| 99 | Waddling gait (HP:0002515) | 2.21292648 |
| 100 | Hip contracture (HP:0003273) | 2.21160403 |
| 101 | Dilated cardiomyopathy (HP:0001644) | 2.17512701 |
| 102 | Gowers sign (HP:0003391) | 2.13993791 |
| 103 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.13461671 |
| 104 | Lower limb muscle weakness (HP:0007340) | 2.13382900 |
| 105 | Prolonged QT interval (HP:0001657) | 2.13088683 |
| 106 | Incomplete penetrance (HP:0003829) | 2.12318026 |
| 107 | Hyperkalemia (HP:0002153) | 2.12076933 |
| 108 | Scapular winging (HP:0003691) | 2.11405268 |
| 109 | Epileptiform EEG discharges (HP:0011182) | 2.08752742 |
| 110 | Fatigable weakness (HP:0003473) | 2.08587522 |
| 111 | Abnormality of the neuromuscular junction (HP:0003398) | 2.08587522 |
| 112 | Excessive salivation (HP:0003781) | 2.07337096 |
| 113 | Drooling (HP:0002307) | 2.07337096 |
| 114 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.04490602 |
| 115 | Myotonia (HP:0002486) | 2.03998436 |
| 116 | Acute necrotizing encephalopathy (HP:0006965) | 2.01839513 |
| 117 | Exercise intolerance (HP:0003546) | 2.01143120 |
| 118 | Difficulty running (HP:0009046) | 2.00962271 |
| 119 | Muscle fiber inclusion bodies (HP:0100299) | 10.9863507 |
| 120 | Nemaline bodies (HP:0003798) | 10.8464057 |
| 121 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.5768665 |
| 122 | Muscular dystrophy (HP:0003560) | 1.99347907 |
| 123 | EEG with generalized epileptiform discharges (HP:0011198) | 1.99273408 |
| 124 | Abnormality of saccadic eye movements (HP:0000570) | 1.98454828 |
| 125 | Insidious onset (HP:0003587) | 1.98329866 |
| 126 | Termporal pattern (HP:0011008) | 1.98329866 |
| 127 | Gait ataxia (HP:0002066) | 1.97453314 |
| 128 | Pheochromocytoma (HP:0002666) | 1.97395253 |
| 129 | Clonus (HP:0002169) | 1.97374871 |
| 130 | Cerebral inclusion bodies (HP:0100314) | 1.97335463 |
| 131 | Lower limb asymmetry (HP:0100559) | 1.96791209 |
| 132 | Ventricular tachycardia (HP:0004756) | 1.96687887 |
| 133 | Insomnia (HP:0100785) | 1.96580267 |
| 134 | Exercise-induced muscle cramps (HP:0003710) | 1.95367177 |
| 135 | Proximal amyotrophy (HP:0007126) | 1.95202086 |
| 136 | Rapidly progressive (HP:0003678) | 1.94930615 |
| 137 | Ankyloglossia (HP:0010296) | 1.92600563 |
| 138 | Rigidity (HP:0002063) | 1.92524033 |
| 139 | Progressive inability to walk (HP:0002505) | 1.91839221 |
| 140 | Hypsarrhythmia (HP:0002521) | 1.91707872 |
| 141 | Heart block (HP:0012722) | 1.91295508 |
| 142 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.90805947 |
| 143 | Obstructive sleep apnea (HP:0002870) | 1.90628626 |
| 144 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.90514929 |
| 145 | Lipoatrophy (HP:0100578) | 1.89948991 |
| 146 | Neurofibrillary tangles (HP:0002185) | 1.89392713 |
| 147 | Abnormality of the periventricular white matter (HP:0002518) | 1.88281921 |
| 148 | Distal lower limb amyotrophy (HP:0008944) | 1.86214066 |
| 149 | Calf muscle hypertrophy (HP:0008981) | 1.85628494 |
| 150 | Generalized myoclonic seizures (HP:0002123) | 1.85478779 |
| 151 | Absent speech (HP:0001344) | 1.84313127 |
| 152 | Limb-girdle muscle atrophy (HP:0003797) | 1.80621712 |
| 153 | Abnormality of the corticospinal tract (HP:0002492) | 1.80348853 |
| 154 | Paralysis (HP:0003470) | 1.80243862 |
| 155 | Spinal rigidity (HP:0003306) | 1.79293445 |
| 156 | Syncope (HP:0001279) | 1.79036927 |
| 157 | Primary atrial arrhythmia (HP:0001692) | 1.77854747 |
| 158 | Nonprogressive disorder (HP:0003680) | 1.77159746 |
| 159 | Tetraplegia (HP:0002445) | 1.76837642 |
| 160 | Achilles tendon contracture (HP:0001771) | 1.75790466 |
| 161 | Progressive muscle weakness (HP:0003323) | 1.75766540 |
| 162 | Shoulder girdle muscle weakness (HP:0003547) | 1.74440991 |
| 163 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.72473739 |
| 164 | Progressive macrocephaly (HP:0004481) | 1.70591278 |
| 165 | Long clavicles (HP:0000890) | 1.70330791 |
| 166 | Increased intramyocellular lipid droplets (HP:0012240) | 1.67575406 |
| 167 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.67103658 |
| 168 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.67103658 |
| 169 | Maternal diabetes (HP:0009800) | 1.66370292 |
| 170 | Abnormality of the foot musculature (HP:0001436) | 1.65294502 |
| 171 | Abnormal atrioventricular conduction (HP:0005150) | 1.64199094 |
| 172 | Abnormality of the calcaneus (HP:0008364) | 1.64147553 |
| 173 | Acute encephalopathy (HP:0006846) | 1.61147186 |
| 174 | Increased purine levels (HP:0004368) | 1.60702777 |
| 175 | Hyperuricemia (HP:0002149) | 1.60702777 |
| 176 | Toxemia of pregnancy (HP:0100603) | 1.59805878 |
| 177 | Short 1st metacarpal (HP:0010034) | 1.58543069 |
| 178 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.58543069 |
| 179 | Decreased subcutaneous fat (HP:0001002) | 1.56902240 |
| 180 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.55207022 |
| 181 | Type 2 muscle fiber atrophy (HP:0003554) | 1.53904929 |
| 182 | Difficulty climbing stairs (HP:0003551) | 1.53091850 |
| 183 | Ulnar deviation of finger (HP:0009465) | 1.52801558 |
| 184 | Abnormality of alanine metabolism (HP:0010916) | 1.51622948 |
| 185 | Hyperalaninemia (HP:0003348) | 1.51622948 |
| 186 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.51622948 |
| 187 | Pelvic girdle muscle weakness (HP:0003749) | 1.51447439 |
| 188 | Ventricular arrhythmia (HP:0004308) | 1.47540357 |
| 189 | Mitochondrial inheritance (HP:0001427) | 1.47423695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.05054465 |
| 2 | TTN | 4.77132533 |
| 3 | NTRK3 | 4.22224850 |
| 4 | MAP3K9 | 3.79694557 |
| 5 | DAPK2 | 3.08003408 |
| 6 | PRKD3 | 2.92416955 |
| 7 | MAP3K4 | 2.54876353 |
| 8 | MINK1 | 2.52917305 |
| 9 | PIK3CG | 2.49844022 |
| 10 | KSR2 | 2.36652420 |
| 11 | PAK6 | 2.34710272 |
| 12 | CAMKK1 | 2.30054309 |
| 13 | MARK1 | 2.11053003 |
| 14 | NTRK1 | 1.92593878 |
| 15 | NTRK2 | 1.91841366 |
| 16 | PRPF4B | 1.89844318 |
| 17 | RIPK4 | 1.84795657 |
| 18 | MAP2K7 | 1.83131620 |
| 19 | DAPK1 | 1.79906190 |
| 20 | MAP2K4 | 1.73580460 |
| 21 | STK38 | 1.69653598 |
| 22 | CDK5 | 1.54540760 |
| 23 | KSR1 | 1.49496001 |
| 24 | TYRO3 | 1.46913050 |
| 25 | MAP3K13 | 1.35109337 |
| 26 | PHKG1 | 1.28731636 |
| 27 | PHKG2 | 1.28731636 |
| 28 | TNIK | 1.26778644 |
| 29 | CDK19 | 1.26468796 |
| 30 | SIK2 | 1.24120426 |
| 31 | CAMKK2 | 1.24070791 |
| 32 | TAOK1 | 1.23988198 |
| 33 | PINK1 | 1.23831994 |
| 34 | RIPK1 | 1.23520637 |
| 35 | GRK5 | 1.18790860 |
| 36 | MAP3K2 | 1.17816455 |
| 37 | ARAF | 1.16536300 |
| 38 | FES | 1.14878088 |
| 39 | MAP2K3 | 1.13982397 |
| 40 | PRKCG | 1.11640737 |
| 41 | CCNB1 | 1.11415963 |
| 42 | CAMK1 | 1.10773396 |
| 43 | STK16 | 1.05980587 |
| 44 | MAPKAPK3 | 1.00620705 |
| 45 | PRKCH | 0.99490907 |
| 46 | MAP3K12 | 0.98399709 |
| 47 | STK11 | 0.97395463 |
| 48 | ERBB3 | 0.97143409 |
| 49 | NEK1 | 0.95136731 |
| 50 | PLK2 | 0.94062839 |
| 51 | UHMK1 | 0.94045147 |
| 52 | PTK2B | 0.91202501 |
| 53 | ALK | 0.91043555 |
| 54 | SGK223 | 0.90875459 |
| 55 | SGK494 | 0.90875459 |
| 56 | MAP3K7 | 0.90739543 |
| 57 | CAMK2A | 0.89015509 |
| 58 | LMTK2 | 0.87889915 |
| 59 | RAF1 | 0.87437833 |
| 60 | PDK2 | 0.87230215 |
| 61 | MAPK13 | 0.86957997 |
| 62 | CDK15 | 0.86256538 |
| 63 | CDK18 | 0.85694725 |
| 64 | OBSCN | 0.85676711 |
| 65 | PDK1 | 0.85126268 |
| 66 | SGK3 | 0.84452227 |
| 67 | GRK1 | 0.82216543 |
| 68 | SGK2 | 0.81737432 |
| 69 | RET | 0.81444052 |
| 70 | DMPK | 0.81090194 |
| 71 | PRKAA2 | 0.80130387 |
| 72 | PDPK1 | 0.77815707 |
| 73 | CDK14 | 0.76763307 |
| 74 | CAMK2B | 0.76062547 |
| 75 | CDK11A | 0.74983648 |
| 76 | SGK1 | 0.74060693 |
| 77 | CAMK4 | 0.71503747 |
| 78 | MARK2 | 0.70821459 |
| 79 | FRK | 0.68491877 |
| 80 | PRKAA1 | 0.68366722 |
| 81 | PAK3 | 0.67957917 |
| 82 | LATS2 | 0.67896702 |
| 83 | PNCK | 0.67700212 |
| 84 | PKN1 | 0.66073716 |
| 85 | LIMK1 | 0.64764345 |
| 86 | MAP2K6 | 0.63571961 |
| 87 | DYRK1B | 0.61684769 |
| 88 | MAP3K1 | 0.59578641 |
| 89 | RPS6KA3 | 0.58481858 |
| 90 | NME1 | 0.58338818 |
| 91 | BMPR2 | 0.57947586 |
| 92 | MOS | 0.57552640 |
| 93 | PRKG1 | 0.57241023 |
| 94 | CASK | 0.56753938 |
| 95 | DAPK3 | 0.56095493 |
| 96 | PRKACA | 0.55458606 |
| 97 | MAPK4 | 0.55077699 |
| 98 | TNK2 | 0.54862427 |
| 99 | TRPM7 | 0.54842134 |
| 100 | PIK3CA | 0.54817220 |
| 101 | CDC42BPA | 0.53899009 |
| 102 | BRSK1 | 0.52905893 |
| 103 | OXSR1 | 0.52777486 |
| 104 | MAPK7 | 0.52731652 |
| 105 | WNK1 | 0.52260259 |
| 106 | DYRK1A | 0.51420476 |
| 107 | EPHB2 | 0.51041741 |
| 108 | AKT2 | 0.50688482 |
| 109 | NEK6 | 0.49937162 |
| 110 | CAMK2G | 0.46327770 |
| 111 | CAMK2D | 0.45977593 |
| 112 | MAPK10 | 0.45417711 |
| 113 | INSRR | 0.44994689 |
| 114 | FYN | 0.44291517 |
| 115 | BCKDK | 0.44139825 |
| 116 | PRKD2 | 0.43140597 |
| 117 | TIE1 | 0.43129912 |
| 118 | TRIB3 | 0.41946253 |
| 119 | MAP2K1 | 0.41561138 |
| 120 | PRKCZ | 0.41511683 |
| 121 | ADRBK2 | 0.39134699 |
| 122 | WNK3 | 0.38881095 |
| 123 | BRAF | 0.37806159 |
| 124 | DDR2 | 0.37264040 |
| 125 | MAPK12 | 0.36928269 |
| 126 | RPS6KB1 | 0.34688501 |
| 127 | DYRK2 | 0.34569801 |
| 128 | MAP4K2 | 0.33195492 |
| 129 | MUSK | 0.31992420 |
| 130 | ROCK1 | 0.31899266 |
| 131 | TAOK2 | 0.31733983 |
| 132 | PDGFRA | 0.31424883 |
| 133 | PRKCE | 0.31370304 |
| 134 | CAMK1G | 0.30652746 |
| 135 | BMPR1B | 0.30214985 |
| 136 | NEK9 | 0.29347743 |
| 137 | PRKCB | 0.29317662 |
| 138 | STK38L | 0.27359022 |
| 139 | NUAK1 | 0.25658296 |
| 140 | MAPK11 | 0.23994071 |
| 141 | RPS6KA1 | 0.23424813 |
| 142 | STK39 | 0.22714360 |
| 143 | PRKACG | 0.22394102 |
| 144 | RPS6KA6 | 0.22186170 |
| 145 | PRKACB | 0.20867048 |
| 146 | LATS1 | 0.20159434 |
| 147 | NLK | 0.18305794 |
| 148 | CSNK1A1 | 0.18186993 |
| 149 | WNK4 | 0.17357687 |
| 150 | PRKCQ | 0.17018744 |
| 151 | PRKD1 | 0.14556861 |
| 152 | PRKDC | 0.14497645 |
| 153 | RPS6KC1 | 0.14392463 |
| 154 | RPS6KL1 | 0.14392463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.27510076 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.93624643 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.91515802 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.79316584 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.78241779 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.65298477 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.63092522 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.61241624 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.58345755 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.51488978 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.51176733 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.49873453 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 2.41889660 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.30660420 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.20548082 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.15245382 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11751590 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 2.03683753 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 2.02287146 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.02254369 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.00888348 |
| 22 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.95694358 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.90962654 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.86950953 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.83507949 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.83231182 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.74634756 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.65931416 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.65877380 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.65632507 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.63228962 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58810136 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.56876571 |
| 34 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.56690764 |
| 35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.56411907 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.52396770 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.52369755 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.47374818 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.45790012 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39336745 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36336939 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.35655564 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34683078 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.33155976 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32063555 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.30750111 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.29069670 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 1.25111691 |
| 49 | Glioma_Homo sapiens_hsa05214 | 1.22888813 |
| 50 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.20720246 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.18313227 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18309603 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16493983 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14857927 |
| 55 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.13674339 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.12726171 |
| 57 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.12167805 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.11501084 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.10271744 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05760459 |
| 61 | Melanogenesis_Homo sapiens_hsa04916 | 1.03117877 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.03012017 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.02577611 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01662229 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01582776 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97230245 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95251035 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94106096 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92975861 |
| 70 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91273337 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.91184902 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91017103 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90045061 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.87828511 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.86588386 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85825846 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84485787 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.82322311 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81795334 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81759177 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80761330 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77640517 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76766328 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74041808 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73652866 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73589335 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73298961 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72712176 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72574059 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72134325 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70471126 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.70321342 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69700298 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.68437254 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68413987 |
| 96 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.67711132 |
| 97 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66790118 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65712921 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65621231 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64381994 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63967412 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63473814 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63268049 |
| 104 | Ribosome_Homo sapiens_hsa03010 | 0.62771773 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60661379 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59704516 |
| 107 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59320995 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59050613 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.58967044 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58018902 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55882683 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53836219 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53108505 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53084741 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.52969442 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52805859 |
| 117 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51179678 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50717415 |
| 119 | Phototransduction_Homo sapiens_hsa04744 | 0.49664766 |
| 120 | RNA degradation_Homo sapiens_hsa03018 | 0.49502205 |
| 121 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48008363 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44423235 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43981112 |
| 124 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43090751 |
| 125 | Alcoholism_Homo sapiens_hsa05034 | 0.42039749 |
| 126 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.41236468 |
| 127 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41005585 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40891336 |
| 129 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39986368 |
| 130 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39142549 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37472810 |
| 132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37358755 |
| 133 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36711872 |
| 134 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36024424 |
| 135 | Purine metabolism_Homo sapiens_hsa00230 | 0.35560391 |
| 136 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35294634 |
| 137 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34813825 |
| 138 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33960510 |
| 139 | Tight junction_Homo sapiens_hsa04530 | 0.33288265 |
| 140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32887412 |
| 141 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32806488 |
| 142 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32584898 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.31908932 |
| 144 | Platelet activation_Homo sapiens_hsa04611 | 0.31628070 |
| 145 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31397540 |
| 146 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.30938390 |
| 147 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30392787 |
| 148 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29779004 |
| 149 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.29090705 |
| 150 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26819549 |
| 151 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.26528864 |

